BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12859868)

  • 1. [Cytomegalovirus retinitis after allogeneic bone marrow transplantation: a case report and literature review].
    Lu J; Huang XJ; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jun; 24(6):312-5. PubMed ID: 12859868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMV retinitis after cessation of ganciclovir therapy for CMV antigenemia in an unrelated BMT recipient.
    Suzuki N; Kudoh T; Mizue N; Watanabe J; Ikehata M; Tateno M; Ooguro H; Chiba S
    Bone Marrow Transplant; 1998 Nov; 22(9):931-2. PubMed ID: 9827825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of cytomegalovirus retinitis in a patient with malignant lymphoma: a case report and review of the literature.
    Kawai Y; Kawai R; Nakayama T; Tanizawa A; Urasaki Y; Fukushima T; Yoshida A; Yamauchi T; Tsutani H; Wano Y; Akagi Y; Ueda T
    Int J Hematol; 1999 Jun; 69(4):256-9. PubMed ID: 10407583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus retinitis in Wegener's granulomatosis: case report and review of the literature.
    Bertelmann E; Liekfeld A; Pleyer U; Hartmann C
    Acta Ophthalmol Scand; 2005 Apr; 83(2):258-61. PubMed ID: 15799746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
    Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gianotti-Crosti syndrome associated with cytomegalovirus antigenemia after bone marrow transplantation.
    Haki M; Tsuchida M; Kotsuji M; Iijima S; Tamura K; Koike K; Izumi I; Tanaka M; Hirano T
    Bone Marrow Transplant; 1997 Oct; 20(8):691-3. PubMed ID: 9383234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMV retinitis after allogeneic bone marrow transplantation: a report of five cases.
    Larsson K; Lönnqvist B; Ringdén O; Hedquist B; Ljungman P
    Transpl Infect Dis; 2002 Jun; 4(2):75-9. PubMed ID: 12220243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased incidence of cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation.
    Xhaard A; Robin M; Scieux C; de Latour RP; Deplus S; Mazeron MC; Devergie A; Espérou H; Rocha V; Gluckman E; Ribaud P; Socié G
    Transplantation; 2007 Jan; 83(1):80-3. PubMed ID: 17220797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for cytomegalovirus retinitis following bone marrow transplantation from unrelated donors in patients with severe aplastic anemia or myelodysplasia.
    Kuriyama K; Todo S; Ikushima S; Fujii N; Yoshihara T; Tsunamoto K; Naya M; Hojo M; Hibi S; Morimoto A; Imashuku S
    Int J Hematol; 2001 Dec; 74(4):455-60. PubMed ID: 11794704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and outcomes of cytomegalovirus retinitis after transplantation.
    Eid AJ; Bakri SJ; Kijpittayarit S; Razonable RR
    Transpl Infect Dis; 2008 Feb; 10(1):13-8. PubMed ID: 17511815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus infection after bone marrow transplantation in children.
    Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G
    Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation.
    Zenz T; Schlenk RF; Glatting G; Neumaier B; Blumstein N; Buchmann I; von Harsdorf S; Ringhoffer M; Wiesneth M; Keller F; Kotzerke J; Röttinger E; Stilgenbauer S; Döhner H; Reske SN; Bunjes D
    J Nucl Med; 2006 Feb; 47(2):278-86. PubMed ID: 16455634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
    Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal complications in patients with solid organ or bone marrow transplantations.
    Chung H; Kim KH; Kim JG; Lee SY; Yoon YH
    Transplantation; 2007 Mar; 83(6):694-9. PubMed ID: 17414700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW; Wu DP; Sun AN; Feng YF; Chang WR; Zhu ZL; Zhu P
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):312-7. PubMed ID: 17877159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
    Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature.
    Kempinska A; Kwak EJ; Angel JB
    Clin Infect Dis; 2005 Nov; 41(9):1277-82. PubMed ID: 16206102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant.
    Ufret-Vincenty RL; Singh RP; Lowder CY; Kaiser PK
    Am J Ophthalmol; 2007 Feb; 143(2):334-5. PubMed ID: 17258523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources.
    Walker CM; van Burik JA; De For TE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1106-15. PubMed ID: 17697973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation.
    Szer J; Durrant S; Schwarer AP; Bradstock KF; Gibson J; Arthur C; To LB; Hughes T; Raunow H
    Intern Med J; 2004 Mar; 34(3):98-101. PubMed ID: 15030456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.